RT Book, Section
A1 Amato, Anthony A.
A1 Russell, James A.
SR Print(0)
ID 1115656802
T1 Principles of Immunomodulating Treatment
T2 Neuromuscular Disorders, 2e
YR 2015
FD 2015
PB McGraw-Hill Education
PP New York, NY
SN 9780071752503
LK neurology.mhmedical.com/content.aspx?aid=1115656802
RD 2024/04/25
AB The  ideal  of  every  patient  and  physician  is  to  identify  a  diagnosis  whose  natural  history  is  self-limited,  or  if  not,  a  diagnosis  for  which  an  effective  treatment  can  be  administered.  Autoimmunity  is  believed  to  be  the  contributing,  if  not  causal,  mechanism  of  a  significant  number  of  neuromuscular  disorders.1  Accordingly,  patients  with  proven  or  suspected  autoimmune  neuromuscular  disorders  become  candidates  for  treatments  that  modulate  or  suppress  immune-mediated  nerve,  neuromuscular  junction,  or  muscle  dysfunction  or  injury.  Familiarity  with  drugs  or  other  interventions  that  suppress  or  modulate  the  patient's  immune  system  is  therefore  a  prerequisite  for  anyone  practicing  neuromuscular  medicine.